Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 826 AL 840

Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network

Tanaka A.

FEBS Lett. 2010 Apr 2;584(7):1386-92. doi: 10.1016/j.febslet.2010.02.060. Epub 2010 Feb 25.

Clinical effects of deep brain stimulation on gait disorders in Parkinson's disease

Wharen R.

Eur J Neurol. 2010 May;17(5):639-40. doi: 10.1111/j.1468-1331.2010.02968.x. Epub 2010 Feb 23.

Alzheimer's disease, Parkinson's disease and essential tremor: three common degenerative diseases with shared mechanisms?

Louis ED, Benito-León J.

Eur J Neurol. 2010 Jun 1;17(6):765-6. doi: 10.1111/j.1468-1331.2010.02976.x. Epub 2010 Feb 26.

Postprandial hypotension

Luciano GL, Brennan MJ, Rothberg MB.

Am J Med. 2010 Mar;123(3):281.e1-6. doi: 10.1016/j.amjmed.2009.06.026.

[The discovery of an antiparkinsonian drug, zonisamide]

Murata M.

Rinsho Shinkeigaku. 2010 Feb;50(2):67-73. doi: 10.5692/clinicalneurol.50.67.

Spinal deformity and Parkinson disease: a treatment algorithm

Upadhyaya CD, Starr PA, Mummaneni PV.

Neurosurg Focus. 2010 Mar;28(3):E5. doi: 10.3171/2010.1.FOCUS09288.

TDP43-positive intraneuronal inclusions in a patient with motor neuron disease and Parkinson's disease

Chanson JB, Echaniz-Laguna A, Vogel T, Mohr M, Benoilid A, Kaltenbach G, Kiesmann M.

Neurodegener Dis. 2010;7(4):260-4. doi: 10.1159/000273591. Epub 2010 Feb 27.

Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report

Stephani C, Trenkwalder C.

Mov Disord. 2010 Apr 30;25(6):790-1. doi: 10.1002/mds.23015.

Long-term antidyskinetic efficacy of amantadine in Parkinson's disease

Wolf E, Seppi K, Katzenschlager R, Hochschorner G, Ransmayr G, Schwingenschuh P, Ott E, Kloiber I, Haubenberger D, Auff E, Poewe W.

Mov Disord. 2010 Jul 30;25(10):1357-63. doi: 10.1002/mds.23034.

Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease

Bronzova J, Sampaio C, Hauser RA, Lang AE, Rascol O, Theeuwes A, van de Witte SV, van Scharrenburg G; Bruegel Study Group.

Mov Disord. 2010 Apr 30;25(6):738-46. doi: 10.1002/mds.22948.

Complementary acupuncture in Parkinson's disease: a spect study

Huang Y, Jiang X, Zhuo Y, Wik G.

Int J Neurosci. 2010 Feb;120(2):150-4. doi: 10.3109/00207450903316527.

Chaotic atrial tachycardia-related ventricular fibrillation in a 2-month-old baby with Wolff-Parkinson-White syndrome

Ko JK, Kim YH, Park IS.

Cardiol Young. 2010 Apr;20(2):214-7. doi: 10.1017/S1047951109992034. Epub 2010 Mar 4.

Rehabilitation in Parkinson's disease: assessing the outcome using objective metabolic measurements

Frazzitta G, Maestri R, Bertotti G, Uccellini D, Bazzini G, Abelli P, Aquilani R.

Mov Disord. 2010 Apr 15;25(5):609-14. doi: 10.1002/mds.22871.

Does age make a difference in caregiver strain? Comparison of young versus older caregivers in early-stage Parkinson's disease

Carter JH, Lyons KS, Stewart BJ, Archbold PG, Scobee R.

Mov Disord. 2010 Apr 30;25(6):724-30. doi: 10.1002/mds.22888.

Mitochondrial metabolism modulation: a new therapeutic approach for Parkinson's disease

Arduíno DM, Esteves AR, Oliveira CR, Cardoso SM.

CNS Neurol Disord Drug Targets. 2010 Mar;9(1):105-19. doi: 10.2174/187152710790966687.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias